Are full body blood test panels with lots of biomarkers worth it? Not always: more markers can mean more false alarms. A 2026 study of 76 wellness panels found 58% of the unique tests lacked screening evidence for healthy people. HOO Longevity in the United States helps you build a focused lab panel that a licensed provider reviews with you. • 9 tests, mostly tumor markers, can trigger chains of extra testing. • Low-value share ranged from 2.8% to 37.9% by platform. • Ask why each marker is there and who reviews it. Learn this with HOO Longevity Academy by Join HOO Health: research-backed lessons and a new reel, carousel and story every day, in your own brand. Free Academy Live class every Tuesday evening. joinhoohealth.com/academy Source: Clin Chem Lab Med, 2026. Education only, not medical advice. Rx programs require an online visit with a licensed provider. Results vary. #longevity #peptidescience #healthyaging #HOOLongevityAcademy #JoinHOOHealth #theUnitedStates